Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis
BackgroundPresurgical molecular therapy (PMT) including tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) showed various outcomes for renal cell carcinoma (RCC) with tumor thrombus (TT). We aimed to evaluate the impact of PMT on…